Show results for
Refine by
Industries served
Antigen Specific Suppliers Serving Monaco
89 companies found
Premium
based inMontigny-le-Bretonneux, FRANCE
Bertin Technologies is a French industrialist in scientific instrumentation that designs and manufactures, in France and in Europe, measurement, observation & detection systems and instruments for critical applications. Every day, Bertin ...
based inCounty of New Castle, DELAWARE (USA)
MedGenome Inc. is a global leader in personalized medicine with unique genomic solutions in immuno-oncology, diabetes, ophthalmology, cardiology and other rare diseases. Founded in 2013, MedGenome currently has a Next Generation Sequencing (NGS) ...
Utilizing targeted next-generation sequencing of these variable regions, can provide deeper insights into B-cell differentiation, BCR somatic hypermutation, class switching, and antigen specificity. Major ...
based inDavis, CALIFORNIA (USA)
Located in Davis, CA, Aves Labs develops novel antibody reagents against neural-specific antigens and epitope tags to foster scientific progress in neuroscience and the molecular biology communities. Aves Labs was co-founded in 1995 by Gary Ciment ...
Our anti-mCherry chicken primary antibody from AvesLabs is manufactured in-house. It detects mCherry, dsRED, RFP (all tested) and tdTOMATO (by similarity) and is purified. It is provided in liquid form. ...
based inLaval, QUEBEC (CANADA)
Biodextris is comprised of experienced product development scientists located in Laval (Montreal), Quebec. The Biodextris Team has worked together in mid and large sized vaccine companies for the past 18 years, now offering our big pharma expertise ...
based inUppsala, SWEDEN
Abera Bioscience is a platform and vaccine development company based on over 30 years of research in the medical, molecular and microbiological field. Abera was founded in 2012 as a spin-out from the Swedish protein production company Xbrane ...
based inNavi Mumbai, INDIA
Yashraj Biotech Limited manufactures a wide range of high pure biomarkers in the form of native and recombinant proteins that are used by the diagnostic industry as controls, calibrators and immunogens. YBL has been the preferred partner of most of ...
Research, development and large scale production of native proteins customized to meet customer’s specifications, for use in diverse biological applications (as controls, calibrators, immunogens ...
based inSan Mateo de Gállego Zaragoza, SPAIN
CerTest Biotec, S.L. is an independent biotechnology company devoted to the development and manufacturing of IVD diagnostic products in human clinical field. An innovative technology-based company whose success lies in its human capital, highly ...
based inLondon, UNITED KINGDOM
Treos Bio is a clinical stage company introducing a disruptive computational technology to change the paradigm of cancer immunotherapy development by resolving the dual challenges of patient and tumor heterogeneity. We use proprietary therapeutic ...
Using our proprietary computational vaccine design technology, we have developed a PolyPEPI preventive peptide vaccine against COVID-19 (SARS-CoV-2). The design of PolyPEPI-SCoV-2 exploits our knowledge on genetic heterogeneity of individuals ...
based inBerlin, GERMANY
Good diagnostic products require high-quality human biomaterials (serums, standards, control samples, purified proteins, and antibodies). Out of this need, we founded ourselves in 1997 as a spin-off of the research department of B.R.A.H.M.S. AG. ...
in.vent quality controls are used for internal and external quality control (e.g. for ring tests) and meet the highest standards of medical laboratories. Our control samples are based on real patient samples and are largely made from native human ...
based inUtrecht, NETHERLANDS
At LAVA, we are focused on applying our expertise in gamma-delta T cell engagers. We are building a pipeline of gamma-delta bsTCEs that have applications in both solid and hematologic malignancies. Our lead program, LAVA-051, targets the tumor ...
LAVA-1207, a gamma-delta bsTCE targeting the prostate specific membrane antigen (PSMA), has also demonstrated preclinical proof-of-concept. We expect to initiate a Phase I/IIa trial in metastatic ...
based inMaryland Heights, MISSOURI (USA)
EastCoast Bio has been a supplier of high quality antigens, antibodies, universal non-mammalian blocking reagents, and specialized immunoassay reagents for the in vitro diagnostic (IVD) manufacturing industry worldwide. Large and small manufacturers ...
based inGießen, GERMANY
Milenia Biotec is dedicated to the development, manufacture and sales of point-of care lateral flow tests, a technology well known from pregnancy testing. The core products of the company are based on “universal test strips”, a concept allowing ...
based inLeichhardt, AUSTRALIA
Atomo Diagnostics Limited is a global leader in the user-centered design of innovative, accurate and reliable rapid diagnostics. Atomo has developed the most consumer friendly platform available for rapid at-home testing. Our integrated testing ...
A fast, accurate point of care COVID-19 antigen test for the qualitative detection of nucleocapsid protein antigens specific to the SARS-CoV-2 virus. Utilising an anterior nasal swab specimen ...
based inNeuried, GERMANY
MIKROGEN's scope of business covers the development, production and distribution of genetically engineered in vitro diagnostics. The company focuses on the serology of bacterial, viral and parasitic infections as well as on auto immune diseases. ...
Recombinant Hepatitis C virus Core protein is expressed in E. coli as a monomeric, non-glycosylated polypeptide chain consisting of 115 amino acids with a molecular mass of 13100 Da. The product represents amino acids 1 to 115 of the HCV ...
based inEastbourne, UNITED KINGDOM
With over 30 years of trading experience, Quadratech Diagnostics Ltd has always been and remains committed to providing the highest quality state-of-the-art medical diagnostic and research products. With over 30 years of trading experience, ...
based inStockholm, SWEDEN
Diamyd Medical is a clinical-stage diabetes company active in the field of pharmaceutical development. We develop two novel disease-modifying drugs: the antigenspecific immunotherapy Diamyd and the oral regenerative and immunomodulatory therapeutic ...
Diamyd® is a suspension for injection containing the active pharmaceutical ingredient GAD65 mixed with the vaccine adjuvant Alhydrogel (alum). The human recombinant protein GAD65 is manufactured in insect cells in a well-controlled GMP process. ...
based inOxford, UNITED KINGDOM
Blue Earth Diagnostics is an established molecular imaging company on a growth trajectory to provide innovative, well differentiated diagnostics solutions, informing patients and driving future therapies in cancer. Formed in 2014, Blue Earth ...
The targeting molecule delivers a therapeutic dose of radiation to kill tumour cells. Blue Earth Diagnostics acquired exclusive, worldwide rights to radiohybrid Prostate Specific Membrane Antigen (rhPSMA) targeted ...
based inNotting Hill, AUSTRALIA
Cartherics is developing its novel “off-the-shelf” (allogeneic) immune therapy products for the treatment of cancer based on immune killer cells. The company is developing large-scale manufacture of these CAR-iNK cells for application in human ...
This technology involves induced pluripotential stem cell (iPSC) derived NK cells (and, potentially, other types of immune cells). iPSCs have unlimited capacity for ...
based inMadison, WISCONSIN (USA)
Through a lot of hard work, a license from the Wisconsin Alumni Research Foundation (WARF) and a desire to have an impact on human health, NeoClone was founded in 1999 by three University of Wisconsin scientists who recognized the need for better ...
based inHamburg, GERMANY
Since 1983, Viramed is one of the leading biotechnology companies for medical laboratory diagnostics. With more than 30 years of experience in the field of infectious and autoimmune serology, Viramed is a successful enterprise, specializing in the ...
The EBV ViraStripe IgG and IgM tests are immunoassays for the qualitative detection of IgG and IgM antibodies against Epstein-Barr Virus antigens in human ...